Traumatic Brain Injury Pipeline Review H1 2017 provides an overview of Traumatic Brain Injury Pipeline landscape. Traumatic Brain Injury is a disease of the eye in which fluid pressure within the eye rises. The exact cause of optic nerve damage from Traumatic Brain Injury is not fully understood, but involves mechanical compression and/or decreased blood flow of the optic nerve. The Traumatic Brain Injury pipeline guide reviews of key players involved in therapeutic development for Traumatic Brain Injury and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 1, 6, 9, 55 and 8 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 10 and 1 molecules, respectively.
Purchase This Traumatic Brain Injury Pipeline Review H1 2017 Report of 252 Pages with Company profiles and Drugs Analysis at http://www.reportsnreports.com/purchase.aspx?name=1125817 .
Report provides comprehensive information on the therapeutics under development for Traumatic Brain Injury, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Traumatic Brain Injury pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Get Discount on This Report at: http://www.reportsnreports.com/contacts/discount.aspx?name=1125817 .
The pipeline guide provides a snapshot of the global therapeutic landscape of Traumatic Brain Injury and reviews pipeline therapeutics for Traumatic Brain Injury by companies and universities/research institutes based on information derived from company and industry-specific sources. This report covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages also features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. Key companies involved in Traumatic Brain Injury therapeutics and enlist all their major and minor projects also reviewed in Traumatic Brain Injury pipeline guide.
Traumatic Brain Injury Pipeline by Companies Analyzed in report: ALSP Inc, Apollo Endosurgery Inc, Aptinyx Inc, Athersys Inc, Beech Tree Labs Inc, Biogen Inc, Cantex Pharmaceuticals Inc, Cognosci Inc, Eustralis Pharmaceuticals Ltd, Intellect Neurosciences Inc, International Stem Cell Corp, Ischemix Inc, JT Pharmaceuticals Inc, Karyopharm Therapeutics Inc, Kyorin Pharmaceutical Co Ltd, Levolta Pharmaceuticals Inc, Lixte Biotechnology Holdings Inc, MandalMed Inc, Mapreg SAS, Neuralstem Inc, Neuren Pharmaceuticals Ltd, Neurofx Inc, NeuroNascent Inc, NeuroVive Pharmaceutical AB, New World Laboratories Inc, NoNO Inc, NuvOx Pharma LLC, Omeros Corp, Oxeia Biopharmaceuticals Inc, Prevacus Inc, QR Pharma Inc, RegeneRx Biopharmaceuticals Inc, Rubicon Biotechnology Inc, Sage Therapeutics Inc, SanBio Inc, STATegics Inc, Stemedica Cell Technologies Inc, SynZyme Technologies LLC, Tetra Discovery Partners LLC, vasopharm GmbH, VG Life Sciences Inc.
Reportsnreports.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries
2nd Floor, Metropole,
Bund Garden Road,
Pune – 411001,
Tel: + 1 888 391 5441